Editor's-Pick

Bharat Biotech’s Covaxin Crosses Another Milestone, Gets Approval for Phase 2, 3 Trials on Children Aged 2-18 years

WebdeskMay 12, 2021, 05:33 PM IST

Bharat Biotech’s Covaxin Crosses Another Milestone, Gets Approval for Phase 2, 3 Trials on Children Aged 2-18 years

The Subject Expert Committee (SEC) has given the approval to Bharat Biotech's Covaxin for Phase 2 and 3 human clinical trials on children aged between two to eighteen years old, sources confirmed on Wednesday. Covaxin is one of the two vaccines being manufactured in India at present and has been developed by Bharat Biotech in association with the Indian Council of Medical Research and the National Institute of Virology. The firm on Tuesday informed that it has been supplying its Covid-19 vaccine directly to 18 states since May 1. "Unflinching in our efforts, we will continue the steady supply of our vaccine," the company tweeted. Maharashtra, Madhya Pradesh, Bihar, Uttar Pradesh, West Bengal and Assam are among the 18 states where the company has been supplying the vaccines directly. Following the Government of India directives, the Hyderabad-based vaccine maker had earlier announced that it will provide Covaxin to state government hospitals at the rate of Rs 400 per dose.

Comments

Also read: Energy Transition in India: An Analysis ..

#RSSIsHere Ready For Selfless Service | RSS India | Rastriya Sewa | Latest 2021 | New | Trending

#RSSIsHere Ready For Selfless Service | RSS India | Rastriya Sewa | Latest 2021 | New | Trending Crisis comes uncalled, but sons of the soil, are the one who hold the nation first irrespective of the situation. The Rashtriya Swayamsevak Sangh has steadfastly performed its duties selflessly. The sangh is also preparing itself for the third wave of Corona and work can be seen in every part of the country. Download Organiser Mobile App: https://play.google.com/store/apps/details?id=org.organiser...

Also read: BJP and Narasimha Rao: From 1991 to 2021 - 30 years of India's march ..

Follow Law of the Land, House Panel Tells Twitter; Our Laws Equally Important, Says Twitter
Tamil Nadu: Attack on BJP legal-wing secretary Aswathaman shows attempts to suppress nationalist voices

Pak Bill on Jadhav has "shortcomings" and is a clear "breach" of basic tenets, says India

New Delhi: India on Thursday, June 17, said that the Pakistani municipal courts cannot be the arbiter on matters of Kulbhushan Jadhav and international law, and said it is high time for Islamabad to take "appropriate steps" to address the shortcomings in the ICJ (Review and Re-consideration) Bill.  "The Bill codifies the earlier Ordinance frankly with all its shortcomings. It does not create machinery to facilitate effective review and reconsideration of Jadhav's case ...

Pak Bill on Jadhav has "shortcomings" and is a clear "breach" of basic tenets, says India